Amadeus invests in Doctify series-A

The startup intends to use the fresh capital to develop its platform and scale-up UK operations.

Amadeus regularly invests in medical-related startups. Its most recent investment in the medical technology space was in September, when it invested in the £1.5m series-A financing round for UK drug repurposing company HealX.

Company
Founded in 2015 and based in London, Doctify is a platform that allows patients to search, compare reviews and prices, and book appointments with medical professionals across the UK. The platform is free to patients, with clinicians paying a monthly fee for listing. Doctify says it helps specialists fill appointments that have been cancelled at short notice and manage their schedules better.

People
Amadeus Capital Partners – Pierre Socha (principal).
Doctify – Oliver Thomas (CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• UK / Ireland
• Technology
• United Kingdom
• Venture
• Amadeus Capital